SKU : MC501402
CAS Number : 1009583-20-3
Molecular Formula : C21H27NO3 | Molecular Weight : 341.44Quote Request
|Storage||at 20ºC 2 years|
* The above information is for reference only.
* If the product has intellectual property rights, a license granted is must or contact us.
BMS-816336 is a novel, potent and orally bioavailable inhibitor against human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme with an IC50 of 3.0 nM. IC50 & Target: IC50: 3.0 nM (11β-HSD1) In Vitro: 11β-HSD1 inhibition may be useful in the treatment of type II diabetes and other potential clinical utilities such as atheroprotection and cognitive protection. BMS-816336 (6n-2) inhibits 11β-HSD1 enzyme in HEK and 3T3L1 cells with IC50s of 37.3 and 28.6 nM, respectively. In Vivo: BMS-816336 represents a potential new treatment for type 2 diabetes, metabolic syndrome, and other human diseases modulated by glucocorticoid control. BMS-816336 (6n-2) exhibits a robust acute pharmacodynamic effect in cynomolgus monkeys (ED50=0.12 mg/kg) and in DIO mice (1, 3, 10, 30, 100 mg/kg, 120 mintues). It is orally bioavailable (%F ranges from 20 to 72% in preclinical species) and has a predicted pharmacokinetic profile of a high peak to trough ratio and short half-life in humans.
© Copyright 2015-2023 Hangzhou MolCore BioPharmatech Co.,Ltd. All rights reserved.